Decreasing the Susceptibility of Malignant Cells to Infection Does Not Impact the Overall Efficacy of Myxoma Virus-Based Oncolytic Virotherapy

Oncolytic virotherapy relies on the induction of anti-tumor immune responses to achieve therapeutic efficacy. The factors that influence the induction of these responses, however, are not well understood. To begin to address this lack of knowledge, we asked how decreasing the susceptibility of malig...

Descripción completa

Detalles Bibliográficos
Autores principales: Flores, Erica B., Bartee, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720075/
https://www.ncbi.nlm.nih.gov/pubmed/33335977
http://dx.doi.org/10.1016/j.omto.2020.10.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720075/
https://www.ncbi.nlm.nih.gov/pubmed/33335977
http://dx.doi.org/10.1016/j.omto.2020.10.011

Ejemplares similares